GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Align Technology Inc (NAS:ALGN) » Definitions » Change In Receivables
中文

Align Technology (Align Technology) Change In Receivables : $-105 Mil (TTM As of Dec. 2023)


View and export this data going back to 2001. Start your Free Trial

What is Align Technology Change In Receivables?

Align Technology's change in receivables for the quarter that ended in Dec. 2023 was $-24 Mil. It means Align Technology's Accounts Receivable increased by $24 Mil from Sep. 2023 to Dec. 2023 .

Align Technology's change in receivables for the fiscal year that ended in Dec. 2023 was $-105 Mil. It means Align Technology's Accounts Receivable increased by $105 Mil from Dec. 2022 to Dec. 2023 .

Align Technology's Accounts Receivable for the quarter that ended in Dec. 2023 was $903 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Align Technology's Days Sales Outstanding for the three months ended in Dec. 2023 was 86.17.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Align Technology's liquidation value for the three months ended in Dec. 2023 was $-655 Mil.


Align Technology Change In Receivables Historical Data

The historical data trend for Align Technology's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Align Technology Change In Receivables Chart

Align Technology Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -121.01 -139.78 -262.07 21.55 -104.61

Align Technology Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.74 -32.73 -40.95 -6.62 -24.32

Align Technology Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-105 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Align Technology  (NAS:ALGN) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Align Technology's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=903.424/956.726*91
=86.17

2. In Ben Graham's calculation of liquidation value, Align Technology's accounts receivable are only considered to be worth 75% of book value:

Align Technology's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=972.742-2453.388+0.75 * 903.424+0.5 * 296.902
=-655

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Align Technology Change In Receivables Related Terms

Thank you for viewing the detailed overview of Align Technology's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Align Technology (Align Technology) Business Description

Traded in Other Exchanges
Address
410 North Scottsdale Road, Suite 1300, Tempe, AZ, USA, 85281
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the FDA in 1998, and it has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans and iTero scans make up over half of these scans.
Executives
Joseph M Hogan director, officer: President and CEO C/O ALIGN TECHNOLOGY, INC., 410 NORTH SCOTTSDALE ROAD, SUITE 1300, TEMPE AZ 85281
Kevin J Dallas director C/O ALIGN TECHNOLOGY INC., 2560 ORCHARD PARKWAY, SAN JOSE CA 95134
John Morici officer: Chief Financial Officer C/O ALIGN TECHNOLOGY INC., 2820 ORCHARD PARKWAY, SAN JOSE CA 94131
Anne Myong director 2820 ORCHARD PARKWAY, SAN JOSE CA 95141
Warren S Thaler director C/O ALIGN TECHNOLOGY, INC., 410 NORTH SCOTTSDALE ROAD, SUITE 1300, TEMPE AZ 85281
Larkin C Raymond Jr director C/O MALLINCKRODT INC, 7733 FORSYTH BLVD, ST LOUIS MO 63105
Julie Ann Coletti officer: SVP, Chief Legal & Regulatory 2820 ORCHARD PARKWAY, SAN JOSE CA 95131
Greg J Santora director 4201 GRANT COURT, PLEASANTON CA 94566
Stuart A Hockridge officer: VP, Global Human Resources C/O ALIGN TECHNOLOGY INC., 2820 ORCHARD PARKWAY, SAN JOSE CA 95131
Emory Wright officer: VP, Operations C/O ALIGN TECHNOLOGY INC., 2820 ORCHARD PARKWAY, SAN JOSE CA 95131
George J Morrow director AMGEN INC., ONE AMGEN CENTER DRIVE, THOUSAND OAKS CA 91320-1799
Andrea Lynn Saia director C/O COCA-COLA ENTERPRISES, INC., 2500 WINDY RIDGE PARKWAY, NW, 14TH FLOOR, ATLANTA GA 30339
Thomas M Prescott director C/O ALIGN TECHNOLOGY INC, 2820 ORCHARD PARKWAY, SAN JOSE CA 95131
Yuval Shaked officer: SVP and Mgng Director, Itero C/O ALIGN TECHNOLOGY INC., 2820 ORCHARD PARKWAY, SAN JOSE CA 95134
Jennifer Olson officer: VP& Mng Dir. D-DCC C/O ALIGN TECHNOLOGY, INC., 2820 ORCHARD PARKWAY, SAN JOSE CA 94131